Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06973785
PHASE3

Non-Narcotic Pain Control After ACL Reconstruction

Sponsor: The Cleveland Clinic

View on ClinicalTrials.gov

Summary

This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narcotics (take zero oxycodone) after undergoing primary knee ACL reconstruction outpatient surgery.

Key Details

Gender

All

Age Range

15 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-07-15

Completion Date

2026-12-31

Last Updated

2025-08-11

Healthy Volunteers

No

Interventions

DRUG

dispense of study drug

• Cohort Group 1 (Experimental): ketorolac 10mg with rescue medication oxycodone 5mg All patients will be given acetaminophen

DRUG

Ketorolac

Patients will be randomized to either Ketorolac or Oxycodone

Locations (3)

Cleveland Clinic Coral Springs

Coral Springs, Florida, United States

Cleveland clinic sports medicine

Garfield, Ohio, United States

Cleveland Clinic

Strongsville, Ohio, United States